Phage Based Diagnostics

01359 231856

Uncategorized

Actiphage blood test could be ‘game changing’ for human TB

May 21, 2019

Tuberculosis (TB) is the leading cause of death from an infectious disease. Although a quarter of the world’s population is thought to carry latent TB, it only progresses to active disease in around 10% of those infected. The reasons for...

Actiphage blood test could be ‘game changing’ for human TB

May 21, 2019

Tuberculosis (TB) is the leading cause of death from an infectious disease. Although a quarter of the world’s population is...

Advantages of Actiphage mycobacteria test highlighted in new explanatory videos

August 31, 2018

Growing demand for PBD Biotech’s phage-based technology has prompted the company to develop a series of explanatory videos.

Advantages of Actiphage mycobacteria test highlighted in new explanatory videos

August 31, 2018

Growing demand for PBD Biotech’s phage-based technology has prompted the company to develop a series of explanatory videos.

developers of phage-based diagnostics

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

design: out of house

PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease